Daniel Vitt
Net Worth
Last updated:
What is Daniel Vitt net worth?
The estimated net worth of Dr. Daniel Vitt is at least $3,436,352 as of 26 Feb 2024. He owns shares worth $368,792 as insider, has earned $20,310 from insider trading and has received compensation worth at least $3,047,250 in Immunic, Inc..
What is the salary of Daniel Vitt?
Dr. Daniel Vitt salary is $609,450 per year as Chief Executive Officer, Pres & Director in Immunic, Inc..
How old is Daniel Vitt?
Dr. Daniel Vitt is 57 years old, born in 1968.
What stocks does Daniel Vitt currently own?
As insider, Dr. Daniel Vitt owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Immunic, Inc. (IMUX) | Chief Executive Officer, Pres & Director | 390,877 | $0.94 | $368,792 |
What does Immunic, Inc. do?
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Daniel Vitt insider trading
Immunic, Inc.
Dr. Daniel Vitt has made 2 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he purchased 14,000 units of IMUX stock worth $18,340 on 26 Feb 2024.
The largest trade he's ever made was exercising 14,000 units of IMUX stock on 26 Feb 2024. As of 26 Feb 2024 he still owns at least 390,877 units of IMUX stock.
Immunic key executives
Immunic, Inc. executives and other stock owners filed with the SEC:
- Dr. Andreas Muehler Ph.D., M.D. (61) Chief Medical Officer
- Dr. Daniel Vitt (57) Chief Executive Officer, Pres & Director
- Dr. Duane D. Nash M.B.A., M.D., J.D., M.B.A (54) Executive Chairman
- Mr. Glenn Whaley (57) Vice President of Fin. and Principal Financial & Accounting Officer